5,940 Shares of Danaher Corporation $DHR Acquired by Bill Few Associates Inc.

Bill Few Associates Inc. acquired a new position in shares of Danaher Corporation (NYSE:DHR) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 5,940 shares of the conglomerate’s stock, valued at approximately $1,316,000.

A number of other large investors also recently added to or reduced their stakes in DHR. Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the fourth quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new stake in Danaher during the second quarter worth about $25,000. Main Street Group LTD purchased a new stake in shares of Danaher during the 1st quarter valued at approximately $25,000. Finally, Field & Main Bank acquired a new position in Danaher in the second quarter valued at approximately $29,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 1.2%

NYSE DHR traded up $2.69 during trading hours on Friday, hitting $220.15. 3,934,329 shares of the company were exchanged, compared to its average volume of 4,457,726. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a market cap of $154.76 billion, a price-to-earnings ratio of 39.10, a PEG ratio of 2.72 and a beta of 0.76. The company has a 50 day moving average of $210.88 and a two-hundred day moving average of $194.44. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the company posted $0.77 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 28.42%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Royal Bank Of Canada lifted their target price on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday. Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. The Goldman Sachs Group increased their price target on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Wells Fargo & Company dropped their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Finally, TD Cowen cut their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $235.23.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.